Premedium Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2018.
2018 Delhi, Delhi, India Active
Last Updated:
Access Report
About Premedium Pharmaceuticals Private Limited

Premedium Pharmaceuticals Private Limited, a active private limited company, was established on 09 October 2018 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24200DL2018PTC340319. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹22.00 Cr and a paid-up capital of ₹21.79 Cr.

It upholds a compliant status. Employing 12 professional, Its leadership includes Sanjiv Kumar Kothari (Director), Saras Malik (Director), Dilip Birdi (Whole-Time Director). Past directors included Rakesh Haldia, Ritesh Kumar, Saras Malik. It holds no open charges and ₹1.00 Cr settled loans. Its latest AGM occurred on 27 June 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 14, Sector - 20, Dwarka, Delhi, Delhi, 110075.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24200DL2018PTC340319

  • Registration Number

    340319

  • Incorporation Date

    09 October 2018

  • Authorized Capital

    ₹22.00 Cr

  • Paid-Up Capital

    ₹21.79 Cr

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 22.00 Cr
  • Paid Up Capital ₹ 21.79 Cr
  • Company Age 7 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.00 Cr
  • Revenue Growth **** -23.70%
  • Profit Growth **** 30.76%
  • Ebitda **** 182.67%
  • Net Worth -136.47%
  • Total Assets -63.60%
Company report

Premedium Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Premedium Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Premedium Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjiv Kumar Kothari Director 09 Oct 2018 Current
Saras Malik Director 14 Aug 2019 Current
Dilip Birdi Whole-Time Director 30 Dec 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 30 Dec 2019 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 02 Aug 2019 Past
Pramod Abcsdd Cfo(Kmp) 30 Jun 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Premedium Pharmaceuticals.

Premedium Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.7% decrease. The company also saw a substantial improvement in profitability, with a 30.76% increase in profit. The company's net worth observed a substantial decline by a decrease of 136.47%.

Premedium Pharmaceuticals revenue growth over time
Premedium Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -23.70%
*******
*******
*******
*******
Revenue from Operations
*******
 -24.19%
*******
*******
*******
*******
Total Assets
*******
 -63.60%
*******
*******
*******
*******
Profit or Loss
*******
 30.76%
*******
*******
*******
*******
Net Worth
*******
 -136.47%
*******
*******
*******
*******
EBITDA
*******
 182.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Premedium Pharmaceuticals?

In 2021, Premedium Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹10,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 1.00 Cr
Latest Charge Details
Date Lender Amount Status
13 Aug 2019 Others ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Premedium Pharmaceuticals?

Premedium Pharmaceuticals has a workforce of 12 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Premedium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premedium Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Premedium Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Premedium Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Jun 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Premedium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was recorded as a recent event.

  • Director Appointment

    The activity Amit Kumar was appointed as a Company Secretary was appointed as a Company Secretary on 20 Mar 2023 & has been associated with this company since 2 years 11 months . was completed.

  • Charges

    The activity A charge registered on 13 Aug 2019 via Charge ID 100286768 with Others was fully satisfied on 13 Feb 2023. was completed.

  • Charges

    The activity A charge with Others of Rs. 1.00 Cr registered on 13 Aug 2019 with Charge ID 100286768 was modified on 15 Oct 2022. was completed.

  • Director Appointment

    The activity Vivek Anand was appointed as a CFO was appointed as a CFO on 15 Sep 2022 & has been associated with this company since 3 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Premedium Pharmaceuticals Private Limited?

The CIN of Premedium Pharmaceuticals Private Limited is U24200DL2018PTC340319.

Where is Premedium Pharmaceuticals Private Limited headquartered?

Premedium Pharmaceuticals Private Limited is headquartered at Plot No. 14, Sector - 20, Dwarka, Delhi, Delhi, 110075.

When was Premedium Pharmaceuticals Private Limited incorporated?

Premedium Pharmaceuticals Private Limited was incorporated on 09 October 2018.

Who are the current directors of Premedium Pharmaceuticals Private Limited?

The current directors of Premedium Pharmaceuticals Private Limited are

What is the primary industry of Premedium Pharmaceuticals Private Limited?

The primary industry of Premedium Pharmaceuticals Private Limited is Manufacturing.

Is Premedium Pharmaceuticals Private Limited a listed company?

Premedium Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Premedium Pharmaceuticals Private Limited?

The authorized capital of Premedium Pharmaceuticals Private Limited is ₹22.00 Cr, and the paid-up capital is ₹21.79 Cr.

What is the compliance status of Premedium Pharmaceuticals Private Limited?

The compliance status of Premedium Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available